Elequin Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-54
| Closed | -$12.7K | – | 306 |
|
|
2024
Q4 | $12.7K | Buy |
54
+8
| +17% | +$1.88K | ﹤0.01% | 282 |
|
|
2024
Q3 | $12.7K | Buy |
+46
| New | +$12.7K | ﹤0.01% | 210 |
|
|
2024
Q2 | – | Sell |
-63
| Closed | -$9.42K | – | 197 |
|
|
2024
Q1 | $9.42K | Buy |
+63
| New | +$9.42K | ﹤0.01% | 111 |
|
|
2023
Q3 | – | Sell |
-70
| Closed | -$13.3K | – | 401 |
|
|
2023
Q2 | $13.3K | Buy |
+70
| New | +$13.3K | 0.01% | 271 |
|